2807 related articles for article (PubMed ID: 24132290)
1. Mutational landscape and significance across 12 major cancer types.
Kandoth C; McLellan MD; Vandin F; Ye K; Niu B; Lu C; Xie M; Zhang Q; McMichael JF; Wyczalkowski MA; Leiserson MDM; Miller CA; Welch JS; Walter MJ; Wendl MC; Ley TJ; Wilson RK; Raphael BJ; Ding L
Nature; 2013 Oct; 502(7471):333-339. PubMed ID: 24132290
[TBL] [Abstract][Full Text] [Related]
2. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer analysis of whole genomes.
ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium
Nature; 2020 Feb; 578(7793):82-93. PubMed ID: 32025007
[TBL] [Abstract][Full Text] [Related]
4. A Pan-Cancer Review of ALK Mutations: Implications for Carcinogenesis and Therapy.
Yau NK; Fong AY; Leung HF; Verhoeft KR; Lim QY; Lam WY; Wong IC; Lui VW
Curr Cancer Drug Targets; 2015; 15(4):327-36. PubMed ID: 25714698
[TBL] [Abstract][Full Text] [Related]
5. Recurrent somatic mutations reveal new insights into consequences of mutagenic processes in cancer.
Stobbe MD; Thun GA; Diéguez-Docampo A; Oliva M; Whalley JP; Raineri E; Gut IG
PLoS Comput Biol; 2019 Nov; 15(11):e1007496. PubMed ID: 31765368
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive characteristics of somatic mutations in the normal tissues of patients with cancer and existence of somatic mutant clones linked to cancer development.
Oh JH; Sung CO
J Med Genet; 2021 Jul; 58(7):433-441. PubMed ID: 32719100
[TBL] [Abstract][Full Text] [Related]
7. Pan-cancer whole-genome analyses of metastatic solid tumours.
Priestley P; Baber J; Lolkema MP; Steeghs N; de Bruijn E; Shale C; Duyvesteyn K; Haidari S; van Hoeck A; Onstenk W; Roepman P; Voda M; Bloemendal HJ; Tjan-Heijnen VCG; van Herpen CML; Labots M; Witteveen PO; Smit EF; Sleijfer S; Voest EE; Cuppen E
Nature; 2019 Nov; 575(7781):210-216. PubMed ID: 31645765
[TBL] [Abstract][Full Text] [Related]
8. The clonal and mutational evolution spectrum of primary triple-negative breast cancers.
Shah SP; Roth A; Goya R; Oloumi A; Ha G; Zhao Y; Turashvili G; Ding J; Tse K; Haffari G; Bashashati A; Prentice LM; Khattra J; Burleigh A; Yap D; Bernard V; McPherson A; Shumansky K; Crisan A; Giuliany R; Heravi-Moussavi A; Rosner J; Lai D; Birol I; Varhol R; Tam A; Dhalla N; Zeng T; Ma K; Chan SK; Griffith M; Moradian A; Cheng SW; Morin GB; Watson P; Gelmon K; Chia S; Chin SF; Curtis C; Rueda OM; Pharoah PD; Damaraju S; Mackey J; Hoon K; Harkins T; Tadigotla V; Sigaroudinia M; Gascard P; Tlsty T; Costello JF; Meyer IM; Eaves CJ; Wasserman WW; Jones S; Huntsman D; Hirst M; Caldas C; Marra MA; Aparicio S
Nature; 2012 Apr; 486(7403):395-9. PubMed ID: 22495314
[TBL] [Abstract][Full Text] [Related]
9. Landscape and function of multiple mutations within individual oncogenes.
Saito Y; Koya J; Araki M; Kogure Y; Shingaki S; Tabata M; McClure MB; Yoshifuji K; Matsumoto S; Isaka Y; Tanaka H; Kanai T; Miyano S; Shiraishi Y; Okuno Y; Kataoka K
Nature; 2020 Jun; 582(7810):95-99. PubMed ID: 32494066
[TBL] [Abstract][Full Text] [Related]
10. Identification of druggable cancer driver genes amplified across TCGA datasets.
Chen Y; McGee J; Chen X; Doman TN; Gong X; Zhang Y; Hamm N; Ma X; Higgs RE; Bhagwat SV; Buchanan S; Peng SB; Staschke KA; Yadav V; Yue Y; Kouros-Mehr H
PLoS One; 2014; 9(5):e98293. PubMed ID: 24874471
[TBL] [Abstract][Full Text] [Related]
11. OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers.
Wang T; Ruan S; Zhao X; Shi X; Teng H; Zhong J; You M; Xia K; Sun Z; Mao F
Nucleic Acids Res; 2021 Jan; 49(D1):D1289-D1301. PubMed ID: 33179738
[TBL] [Abstract][Full Text] [Related]
12. Age influences on the molecular presentation of tumours.
Li CH; Haider S; Boutros PC
Nat Commun; 2022 Jan; 13(1):208. PubMed ID: 35017538
[TBL] [Abstract][Full Text] [Related]
13. The landscape of cancer genes and mutational processes in breast cancer.
Stephens PJ; Tarpey PS; Davies H; Van Loo P; Greenman C; Wedge DC; Nik-Zainal S; Martin S; Varela I; Bignell GR; Yates LR; Papaemmanuil E; Beare D; Butler A; Cheverton A; Gamble J; Hinton J; Jia M; Jayakumar A; Jones D; Latimer C; Lau KW; McLaren S; McBride DJ; Menzies A; Mudie L; Raine K; Rad R; Chapman MS; Teague J; Easton D; Langerød A; ; Lee MT; Shen CY; Tee BT; Huimin BW; Broeks A; Vargas AC; Turashvili G; Martens J; Fatima A; Miron P; Chin SF; Thomas G; Boyault S; Mariani O; Lakhani SR; van de Vijver M; van 't Veer L; Foekens J; Desmedt C; Sotiriou C; Tutt A; Caldas C; Reis-Filho JS; Aparicio SA; Salomon AV; Børresen-Dale AL; Richardson AL; Campbell PJ; Futreal PA; Stratton MR
Nature; 2012 May; 486(7403):400-4. PubMed ID: 22722201
[TBL] [Abstract][Full Text] [Related]
14. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution.
McGranahan N; Favero F; de Bruin EC; Birkbak NJ; Szallasi Z; Swanton C
Sci Transl Med; 2015 Apr; 7(283):283ra54. PubMed ID: 25877892
[TBL] [Abstract][Full Text] [Related]
15. Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors.
Hafner C; Toll A; Fernández-Casado A; Earl J; Marqués M; Acquadro F; Méndez-Pertuz M; Urioste M; Malats N; Burns JE; Knowles MA; Cigudosa JC; Hartmann A; Vogt T; Landthaler M; Pujol RM; Real FX
Proc Natl Acad Sci U S A; 2010 Nov; 107(48):20780-5. PubMed ID: 21078999
[TBL] [Abstract][Full Text] [Related]
16. Mutational landscape of RNA-binding proteins in human cancers.
Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
[TBL] [Abstract][Full Text] [Related]
17. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
[TBL] [Abstract][Full Text] [Related]
18. Genomic landscape and mutational impacts of recurrently mutated genes in cancers.
Liu B; Hu FF; Zhang Q; Hu H; Ye Z; Tang Q; Guo AY
Mol Genet Genomic Med; 2018 Nov; 6(6):910-923. PubMed ID: 30107644
[TBL] [Abstract][Full Text] [Related]
19. Diverse somatic mutation patterns and pathway alterations in human cancers.
Kan Z; Jaiswal BS; Stinson J; Janakiraman V; Bhatt D; Stern HM; Yue P; Haverty PM; Bourgon R; Zheng J; Moorhead M; Chaudhuri S; Tomsho LP; Peters BA; Pujara K; Cordes S; Davis DP; Carlton VE; Yuan W; Li L; Wang W; Eigenbrot C; Kaminker JS; Eberhard DA; Waring P; Schuster SC; Modrusan Z; Zhang Z; Stokoe D; de Sauvage FJ; Faham M; Seshagiri S
Nature; 2010 Aug; 466(7308):869-73. PubMed ID: 20668451
[TBL] [Abstract][Full Text] [Related]
20. Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
Ding L; Bailey MH; Porta-Pardo E; Thorsson V; Colaprico A; Bertrand D; Gibbs DL; Weerasinghe A; Huang KL; Tokheim C; Cortés-Ciriano I; Jayasinghe R; Chen F; Yu L; Sun S; Olsen C; Kim J; Taylor AM; Cherniack AD; Akbani R; Suphavilai C; Nagarajan N; Stuart JM; Mills GB; Wyczalkowski MA; Vincent BG; Hutter CM; Zenklusen JC; Hoadley KA; Wendl MC; Shmulevich L; Lazar AJ; Wheeler DA; Getz G;
Cell; 2018 Apr; 173(2):305-320.e10. PubMed ID: 29625049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
